The inhibition of placental mTOR signaling leads to fetal growth restriction with abnormal glucose metabolism in different anatomical regions of placentas
Placenta · 2025
DOI: 10.1016/j.placenta.2025.03.008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Placenta, 2025. Verfasst von Qian Xu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Tangdu Hospital, Air Force Medical University, Xi'an, Shaanxi Province, China; Reproductive Medicine Departm…. Hauptthemen laut MEDLINE: Fetal Growth Retardation, Placenta, TOR Serine-Threonine Kinases, Glucose. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
INTRODUCTION: Fetal growth restriction (FGR) is a common pregnancy complication with significant impact on obstetric and birth outcomes. Increasing evidence shows that the inhibition of placental mechanistic target of rapamycin (mTOR) signaling is closely related to FGR. However, the pathogenesis of FGR is not fully consistent presently, which is subject to the methodological divergence. METHODS: Rapamycin was used to construct the FGR mouse model. Hematoxylin & eosin (HE) and periodic acid-schiff (PAS) staining were used to analyze the morphology of mouse placenta. Western blot was used to analyze the expression levels of glucose transporters and key enzymes associated with glycogen metabolism in human/mouse placental tissues in different anatomic layers. HTR-8 cells were treated with dimethyl sulfoxide (DMSO) or rapamycin (2 mM) for 24 h. Cell viability was detected by CCK8 kit. In addition, glycogen concentration in placental tissue or cell samples was detected by Glycogen Assay Kit. RESULTS: Firstly, we observed a significant reduction of glucose content in different anatomical regions of human small-for-gestational-age (SGA) placenta, also glucose metabolism was undermined to some extent. Then, we found that FGR placentas showed abnormal morphological changes, the glycogen levels in FGR placentas were significantly reduced by quantitative detection. Meanwhile, the expression levels of glucose transporters, Gys1 and p-Gsk3β in FGR placentas were reduced compared to controls. The HTR-8 cells treated with rapamycin revealed decreasing mTOR activity and glycogen levels. In addition, glucose transporter, GYS1, p-GSK3β expressions were all significantly reduced and t-GSK3β level was significantly elevated. DISCUSSION: Overall, our data indicate that inhibition of placental mTOR signaling may contribute to the occurrence of FGR by altering glucose metabolism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Tangdu Hospital, Air Force Medical University, Xi'an, Shaanxi Province, China; Reproductive Medicine Department, General Hospital of Chinese PLA Central Theater Command, Wuhan, 4…
- Department of Obstetrics and Gynecology, Tangdu Hospital, Air Force Medical University, Xi'an, Shaanxi Province, China.
- Unit 95885 of the People's Liberation Army, China.
- Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Xi'an Medical University, Xi'an, Shaanxi Province, China.
- Department of Obstetrics and Gynecology, Tangdu Hospital, Air Force Medical University, Xi'an, Shaanxi Province, China. Electronic address: dongjie2020@fmmu.edu.cn.
- Department of Obstetrics and Gynecology, Tangdu Hospital, Air Force Medical University, Xi'an, Shaanxi Province, China. Electronic address: wangxh919@fmmu.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Xu, Q., Wang, J., Li, Y., Lei, H., Jin, N., Lu, J., Qian, C., Zhang, J., Dong, J., & Wang, X. (2025). The inhibition of placental mTOR signaling leads to fetal growth restriction with abnormal glucose metabolism in different anatomical regions of placentas. Placenta. https://doi.org/10.1016/j.placenta.2025.03.008
Vancouver
Xu Q, Wang J, Li Y, Lei H, Jin N, Lu J, et al. The inhibition of placental mTOR signaling leads to fetal growth restriction with abnormal glucose metabolism in different anatomical regions of placentas. Placenta. 2025. doi:10.1016/j.placenta.2025.03.008
BibTeX
@article{Xu2025,
author = {Xu, Qian and Wang, Jingjing and Li, Yajing and Lei, Hui and Jin, Ni and Lu, Jie and Qian, Chenxi and Zhang, Jianhua and Dong, Jie and Wang, Xiaohong},
title = {The inhibition of placental mTOR signaling leads to fetal growth restriction with abnormal glucose metabolism in different anatomical regions of placentas},
journal = {Placenta},
year = {2025},
doi = {10.1016/j.placenta.2025.03.008}
}
EUVIMED